Målestokken for virkningen af ZOSTAVAX var antallet af personer, som havde fået helvedesild og postherpetiske smerter i løbet af undersøgelsesperioden.
The measure of the effectiveness of ZOSTAVAX was based on the number of people who developed shingles and post-herpetic pain during the study.